TY  - JOUR
AU  - Hugo, González Saldivar
AU  - Figueiras-Graillet, Lourdes M
AU  - Anguita, Manuel
AU  - Marín, Francisco
AU  - Bertomeu, Vicente
AU  - Roldán, Inmaculada
AU  - Ruiz, Martín
AU  - Muñiz, Javier
AU  - Martínez-Sellés, Manuel
AU  - FANTASIIA registry investigators (see Appendix)
PY  - 2016
DO  - 10.1016/j.ijcard.2016.08.004
UR  - http://hdl.handle.net/10668/10362
T2  - International journal of cardiology
AB  - Vitamin K antagonists (VKAs) are still largely employed, even in nonvalvular atrial fibrillation (AF). Our aim was to study the clinical profile of octogenarians treated with oral anticoagulation and to study the effect of age on the quality of VKAs...
LA  - en
KW  - Age
KW  - Atrial fibrillation
KW  - Octogenarians
KW  - Time in therapeutic range
KW  - Vitamin K antagonists
KW  - Administration, Oral
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Anticoagulants
KW  - Atrial Fibrillation
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Incidence
KW  - Male
KW  - Prospective Studies
KW  - Registries
KW  - Risk Assessment
KW  - Risk Factors
KW  - Spain
KW  - Stroke
KW  - Survival Rate
KW  - Treatment Outcome
TI  - Oral anticoagulation in octogenarians with atrial fibrillation.
TY  - research article
VL  - 223
ER  -